1 – 75 of 75
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate
ETV6::RUNX1-positive leukemia cells in preclinical models.
(
- Contribution to journal › Article
-
Mark
Engineered human Diamond-Blackfan anemia disease model confirms therapeutic effects of clinically applicable lentiviral vector at single-cell resolution
(
- Contribution to journal › Article
-
Mark
Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A : data from the PedNet Hemophilia Cohort of 1,202 children
(
- Contribution to journal › Article
- 2022
-
Mark
Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017
(
- Contribution to journal › Letter
-
Mark
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
(
- Contribution to journal › Letter
-
Mark
Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector
(
- Contribution to journal › Article
- 2021
-
Mark
Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B : a PedNet study
(
- Contribution to journal › Article
-
Mark
Combinatorial molecule screening identifies a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells
(
- Contribution to journal › Article
-
Mark
Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
(
- Contribution to journal › Article
- 2020
-
Mark
Early growth response 1 regulates hematopoietic support and proliferation in human primary bone marrow stromal cells
(
- Contribution to journal › Article
- 2019
-
Mark
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Mode of delivery in hemophilia : Vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds
(
- Contribution to journal › Article
-
Mark
First line therapy in chronic lymphocytic leukemia : a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013
(
- Contribution to journal › Article
-
Mark
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study : high white blood cell count at diagnosis is the strongest prognostic factor
(
- Contribution to journal › Article
-
Mark
Endothelial protein C receptor (EPCR) expression marks human fetal liver hematopoietic stem cells
(
- Contribution to journal › Article
-
Mark
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells
(
- Contribution to journal › Article
- 2018
-
Mark
Acute myeloid leukemia in very old patients
(
- Contribution to journal › Article
-
Mark
Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma
(
- Contribution to journal › Letter
- 2017
-
Mark
Distinct global binding patterns of the Wilms' tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells
(
- Contribution to journal › Article
-
Mark
Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
(
- Contribution to journal › Article
- 2016
-
Mark
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2015
-
Mark
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells
(
- Contribution to journal › Letter
-
Mark
Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease
(
- Contribution to journal › Letter
-
Mark
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase 2 study by The Nordic Lymphoma Group.
(
- Contribution to journal › Article
-
Mark
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
(
- Contribution to journal › Letter
-
Mark
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.
(
- Contribution to journal › Article
-
Mark
UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
2015) In Haematologica(
- Contribution to journal › Article
- 2014
-
Mark
t(6;9)(p22; q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients
(
- Contribution to journal › Article
-
Mark
Gene therapy cures the anemia and lethal bone marrow failure in mouse model for RPS19-deficient Diamond-Blackfan anemia.
(
- Contribution to journal › Article
-
Mark
Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study
(
- Contribution to journal › Article
-
Mark
The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease
(
- Contribution to journal › Article
- 2013
-
Mark
Osteoclasts are not crucial for hematopoietic stem cell maintenance in adult mice
(
- Contribution to journal › Article
-
Mark
High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols
(
- Contribution to journal › Article
-
Mark
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
(
- Contribution to journal › Article
- 2012
-
Mark
High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
(
- Contribution to journal › Article
-
Mark
Remission maintenance in acute myeloid leukemia: impact of functional histamine H-2 receptors expressed by leukemic cells
(
- Contribution to journal › Article
-
Mark
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders
(
- Contribution to journal › Article
- 2011
-
Mark
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
(
- Contribution to journal › Article
- 2010
-
Mark
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
-
Mark
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
- 2009
-
Mark
4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins
(
- Contribution to journal › Article
-
Mark
Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance
(
- Contribution to journal › Letter
-
Mark
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies
(
- Contribution to journal › Scientific review
-
Mark
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study
(
- Contribution to journal › Article
-
Mark
Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma.
(
- Contribution to journal › Article
-
Mark
In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodies
(
- Contribution to journal › Article
-
Mark
Autoimmunity and risk for Hodgkin's lymphoma by subtype
(
- Contribution to journal › Letter
- 2008
-
Mark
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation
(
- Contribution to journal › Article
-
Mark
Variability of clinical manifestations of factor VII-deficiency in subjects homozygous or heterozygous for the F7 gene mutation A294V
(
- Contribution to journal › Letter
-
Mark
An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia : a multi-center study of 381 patients
(
- Contribution to journal › Article
- 2007
-
Mark
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)
(
- Contribution to journal › Article
- 2006
-
Mark
Cross-platform classification in microarray-based leukemia diagnostics
(
- Contribution to journal › Article
-
Mark
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
(
- Contribution to journal › Article
-
Mark
The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK
(
- Contribution to journal › Letter
-
Mark
MLL/GAS7 fusion in a pediatric case of t(11;17)(q23;p13)-positive precursor B-cell acute lymphoblastic leukemia
(
- Contribution to journal › Letter
-
Mark
Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes
(
- Contribution to journal › Article
- 2005
-
Mark
The Malmö International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A.
(
- Contribution to journal › Article
-
Mark
Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions.
(
- Contribution to journal › Article
-
Mark
Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model
(
- Contribution to journal › Article
- 2004
-
Mark
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders
(
- Contribution to journal › Article
-
Mark
Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy
(
- Contribution to journal › Letter
-
Mark
Low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma
(
- Contribution to journal › Article
-
Mark
Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis
(
- Contribution to journal › Article
- 2003
-
Mark
Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?
(
- Contribution to journal › Article
- 2002
-
Mark
Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.
(
- Contribution to journal › Article
- 2000
-
Mark
Regimens of factor VIII administration--continuous infusion vs. bolus
(
- Contribution to journal › Article
-
Mark
Immune tolerance induction and the treatment of hemophilia. Malmo protocol update
(
- Contribution to journal › Article